Cargando…

Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia

The regulator of G-protein signaling (RGS) modulates the functioning of heterotrimeric G protein. RGS9-2 is highly expressed in the striatum and plays a role in modulating dopaminergic receptor-mediated signaling cascades. Previous studies suggested that the RGS9 gene might contribute to the suscept...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okahisa, Y, Kodama, M, Takaki, M, Inada, T, Uchimura, N, Yamada, M, Iwata, N, Iyo, M, Sora, I, Ozaki, N, Ujike, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137179/ https://www.ncbi.nlm.nih.gov/pubmed/21886588 http://dx.doi.org/10.2174/157015911795017029

Ejemplares similares

Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence
por: Okahisa, Y, et al.
Publicado: (2011)

Association Between 5HT1b Receptor Gene and Methamphetamine Dependence
por: Ujike, H, et al.
Publicado: (2011)

Association Study of Serine Racemase Gene with Methamphetamine Psychosis
por: Yokobayashi, E, et al.
Publicado: (2011)

The Frizzled 3 gene is associated with methamphetamine psychosis in the Japanese population
por: Kishimoto, Makiko, et al.
Publicado: (2008)

Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese
por: Okochi, T, et al.
Publicado: (2011)

Association Analysis of the Tryptophan Hydroxylase 2 Gene Polymorphisms in Patients with Methamphetamine Dependence/Psychosis
por: Kobayashi, Hideaki, et al.
Publicado: (2011)

The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population
por: Kobayashi, Hideaki, et al.
Publicado: (2010)

Association Analysis of the Adenosine A1 Receptor Gene Polymorphisms in Patients with Methamphetamine Dependence/Psychosis
por: Kobayashi, Hideaki, et al.
Publicado: (2011)

Association Analysis of Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Japanese Methamphetamine Dependence
por: Kishi, Taro, et al.
Publicado: (2011)

Lack of Association Between Prokineticin 2 Gene and Japanese Methamphetamine Dependence
por: Kishi, Taro, et al.
Publicado: (2011)

No Association Between GRM3 and Japanese Methamphetamine-Induced Psychosis
por: Tsunoka, Tomoko, et al.
Publicado: (2011)

Genetic Association Analysis of NOS1 and Methamphetamine-Induced Psychosis Among Japanese
por: Okumura, Takenori, et al.
Publicado: (2011)

Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders
por: Ishizuka, K, et al.
Publicado: (2017)

A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility
por: Kimura, H, et al.
Publicado: (2017)

Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia
por: Ishizuka, Kanako, et al.
Publicado: (2020)

Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
por: Mizuki, Yutaka, et al.
Publicado: (2020)

Genome-wide association study identifies a potent locus associated with human opioid sensitivity
por: Nishizawa, D, et al.
Publicado: (2014)

Factors predicting work outcome in Japanese patients with schizophrenia: role of multiple functioning levels
por: Sumiyoshi, Chika, et al.
Publicado: (2015)

Rare single-nucleotide DAB1 variants and their contribution to Schizophrenia and autism spectrum disorder susceptibility
por: Nawa, Yoshihiro, et al.
Publicado: (2020)

Application of eye trackers for understanding mental disorders: Cases for schizophrenia and autism spectrum disorder
por: Shishido, Emiko, et al.
Publicado: (2019)

Correlates of Aggression in Men With Methamphetamine Use Disorder: Childhood Trauma and Methamphetamine-Use Characteristics
por: Liu, Mengqi, et al.
Publicado: (2022)

Effect of risperidone on the cravings of patients with methamphetamine use disorder
por: Hassan, N., et al.
Publicado: (2022)

Oxytocin, a Novel Treatment for Methamphetamine Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2022)

A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder
por: Ikeda, M, et al.
Publicado: (2018)

Electroencephalographic delta/alpha frequency activity differentiates psychotic disorders: a study of schizophrenia, bipolar disorder and methamphetamine-induced psychotic disorder
por: Howells, Fleur M, et al.
Publicado: (2018)

Δ9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity
por: Castelli, M. Paola, et al.
Publicado: (2014)

Genetic Variants on 3q21 and in the Sp8 Transcription Factor Gene (SP8) as Susceptibility Loci for Psychotic Disorders: A Genetic Association Study
por: Kondo, Kenji, et al.
Publicado: (2013)

Methamphetamine Increases Locomotion and Dopamine Transporter Activity in Dopamine D5 Receptor-Deficient Mice
por: Hayashizaki, Seiji, et al.
Publicado: (2013)

Cognitive Functioning in Schizophrenia, Methamphetamine-induced Psychotic Disorder, and Healthy People: A Comparative Study
por: Khalkhali, Mohammadrasoul, et al.
Publicado: (2018)

The Comparison Between Positive and Negative Symptoms Severity in Prolonged Methamphetamine-induced Psychotic Disorder and Schizophrenia
por: Ahmadkhaniha, Hamidreza, et al.
Publicado: (2022)

Long-Term Protective Effects of Methamphetamine Preconditioning Against Single-Day Methamphetamine Toxic Challenges
por: Hodges, A.B, et al.
Publicado: (2011)

Rare genetic variants in the gene encoding histone lysine demethylase 4C (KDM4C) and their contributions to susceptibility to schizophrenia and autism spectrum disorder
por: Kato, Hidekazu, et al.
Publicado: (2020)

The Effect of Chronic Methamphetamine Treatment on Schizophrenia Endophenotypes in Heterozygous Reelin Mice: Implications for Schizophrenia
por: Hume, Camilla, et al.
Publicado: (2020)

Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research
por: Guerin, Alexandre A., et al.
Publicado: (2019)

Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine
por: Haile, Colin N., et al.
Publicado: (2022)

Mice carrying a schizophrenia-associated mutation of the Arhgap10 gene are vulnerable to the effects of methamphetamine treatment on cognitive function: association with morphological abnormalities in striatal neurons
por: Hada, Kazuhiro, et al.
Publicado: (2021)

Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype
por: Uno, Kyosuke, et al.
Publicado: (2016)

Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese population
por: Kimura, Hiroki, et al.
Publicado: (2015)

Cognitive functions in methamphetamine induced psychosis compared to schizophrenia and normal subjects
por: Ezzatpanah, Zahra, et al.
Publicado: (2014)

Epigenetic Landscape of Methamphetamine Use Disorder
por: Cadet, Jean Lud, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dc8i04r42nkebq6lfpe52mg2rv